Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114057625A details a green electrochemical route for C2-acyloxy-3-indolinone derivatives, offering metal-free synthesis and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112424149B details a novel recycling method for Tipifarnib synthesis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN112110951A reveals a novel aqueous-phase radical coupling method for Bryostatin C-ring precursors, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Explore CN1108653A technology for synthesizing hyper-potent paclitaxel analogs. Offers superior solubility and antitumor activity for reliable API intermediate supply chains.
Novel green route for Sonidegib intermediates via epoxide ring-opening. Eliminates expensive chiral starting materials and reduces wastewater for cost-effective manufacturing.
Novel industrial method for Dasatinib synthesis avoiding palladium catalysts, offering cost reduction and scalable production for pharmaceutical manufacturers.
Discover a novel 3-step synthesis for Lenalidomide intermediates using glutarimide. Achieve high purity and significant cost reduction in pharma manufacturing with scalable routes.
Patent CN114230568B details a high-yield 4-step route for HER2 inhibitor Tucatinib using Pd(acac)2, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103408559B reveals a rapid synthesis for camptothecin analogues. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Advanced chiral resolution technology for Crizotinib intermediates ensures high purity and cost reduction in API manufacturing for global supply chains.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN109096148B reveals a novel one-pot method for Vorinostat using modified mesoporous silica, offering high purity and simplified supply chain for pharmaceutical manufacturers.
Patent CN109503511B reveals a novel 2-step synthesis for dasatinib intermediates using PEG 400, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113336742B details a novel 3-step synthesis for Pyrrotinib intermediates, offering significant cost reduction and improved scalability for API manufacturing.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN114907300B details a cost-effective route for Tazemetostat intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN113651800A reveals a high-yield route for Oxitinib Mesylate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103601777A details a high-purity capecitabine preparation method using isopropyl ether crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.